Sigma will import Russian drug against Covid-19 and produce it in Cochabamba

The Bolivian company Sigma will import the Russian drug Avifavir, designed to combat Covid-19, and will subsequently produce it in its laboratories in Cochabamba, once the necessary procedures completed. According to the agreement, Russia will sell at least 150,000 packages of Avifavir. It will transfer the technology for producing the final dose to its partner in Bolivia, which will reduce the waiting period and logistics costs, as well as the time needed to introduce Avifavir in the treatment of coronavirus.

Source: Los Tiempos